A Study of LY2940680 in Healthy Participants

Status Completed

Clinical Trial Summary

This study involves 2 parts, Part A and Part B. The purpose of Part A is to evaluate the safety and side effects of LY2940680 in healthy participants. Part A will involve two groups of participants, each taking up to two single doses of LY2940680 at different dose levels. There is a minimum 14 day washout period between each of the participant's doses. The purpose of Part B is to study how much of the study drug, in capsule or tablet form, gets into the bloodstream and how long the body takes to get rid of it. In addition, the effect of food and a proton pump inhibitor (PPI) on LY2940680 will be studied. Part B will involve one group of participants who will take four single doses of 100 milligrams (mg) LY2940680. There is a minimum 7 day washout period between doses. Participants may only enroll in one part. Screening is required within 28 days prior to the start of the study.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Healthy Participants

Clinical Trial Details

NCT number	NCT01681186
Study type	Interventional
Source	Eli Lilly and Company
Contact
Status	Completed
Phase	Phase 1
Start date	September 2012
Completion date	December 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05445440` - A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine	Phase 1
Completed	`NCT03712540` - An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants	Phase 1
Completed	`NCT03649165` - A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male Participants	Phase 1
Completed	`NCT05956002` - A Study to Evaluate the Study Medication (Etrasimod) When Mixed With Food in Healthy Participants	Phase 1
Completed	`NCT05539976` - A Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants
Withdrawn	`NCT04558216` - Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy Participants	Phase 1
Withdrawn	`NCT03007771` - Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia	Phase 1
Completed	`NCT06097390` - A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III	Phase 1
Completed	`NCT05546151` - A Study to Assess the Safety and Tolerability of BMS-986322 in Healthy Participants of Japanese Descent	Phase 1
Completed	`NCT05056246` - Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants	Phase 1
Completed	`NCT04390776` - Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules.	Phase 1
Completed	`NCT05074459` - A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines	Phase 1
Enrolling by invitation	`NCT06089109` - Creating VIP Corps to Reduce Maternal Deaths	N/A
Completed	`NCT05996250` - Tolerance of an Immersive Virtual Reality Task Evaluating the Spatial Memory of Elderly Subjects	N/A
Completed	`NCT03278080` - Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #1	N/A
Completed	`NCT05064800` - PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy Participants	Phase 1
Completed	`NCT04471298` - A Study of Qishenyiqi Dripping Pills in Healthy Participants	Phase 1
Completed	`NCT04914936` - A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196	Phase 1
Completed	`NCT02563262` - Human Neutral Body Posture in Weightlessness	N/A
Completed	`NCT02882386` - Amino Acid Kinetics in Blood After Consuming Different Milk Protein Supplements	N/A